HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 183 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | 0.0% | 151 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | -100.0% | 151 | -100.0% | 0.00% | -100.0% |
| Q1 2022 | $31,689,000 | -17.5% | 651,372 | -27.7% | 2.15% | +1.1% |
| Q4 2021 | $38,411,000 | -47.3% | 900,824 | -52.6% | 2.12% | -32.7% |
| Q3 2021 | $72,859,000 | -3.2% | 1,900,824 | -28.7% | 3.16% | +13.0% |
| Q2 2021 | $75,274,000 | -14.6% | 2,666,456 | -0.1% | 2.79% | -10.9% |
| Q1 2021 | $88,180,000 | -8.6% | 2,668,897 | 0.0% | 3.13% | +8.0% |
| Q4 2020 | $96,481,000 | +6.6% | 2,668,897 | 0.0% | 2.90% | -3.7% |
| Q3 2020 | $90,476,000 | – | 2,668,897 | – | 3.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |